» Articles » PMID: 29773874

Mutations in Six Nephrosis Genes Delineate a Pathogenic Pathway Amenable to Treatment

Abstract

No efficient treatment exists for nephrotic syndrome (NS), a frequent cause of chronic kidney disease. Here we show mutations in six different genes (MAGI2, TNS2, DLC1, CDK20, ITSN1, ITSN2) as causing NS in 17 families with partially treatment-sensitive NS (pTSNS). These proteins interact and we delineate their roles in Rho-like small GTPase (RLSG) activity, and demonstrate deficiency for mutants of pTSNS patients. We find that CDK20 regulates DLC1. Knockdown of MAGI2, DLC1, or CDK20 in cultured podocytes reduces migration rate. Treatment with dexamethasone abolishes RhoA activation by knockdown of DLC1 or CDK20 indicating that steroid treatment in patients with pTSNS and mutations in these genes is mediated by this RLSG module. Furthermore, we discover ITSN1 and ITSN2 as podocytic guanine nucleotide exchange factors for Cdc42. We generate Itsn2-L knockout mice that recapitulate the mild NS phenotype. We, thus, define a functional network of RhoA regulation, thereby revealing potential therapeutic targets.

Citing Articles

Enhancing diagnostic outcomes in kidney genetic disorders: the KidGen national kidney genomics study protocol.

Mallawaarachchi A, McCarthy H, Forbes T, Jayasinghe K, Patel C, Alexander S BMC Nephrol. 2025; 26(1):51.

PMID: 39901087 PMC: 11792728. DOI: 10.1186/s12882-024-03926-y.


Mechanisms of podocyte injury in genetic kidney disease.

Mann N, Sun H, Majmundar A Pediatr Nephrol. 2024; .

PMID: 39485497 DOI: 10.1007/s00467-024-06551-x.


Comprehensive circular RNA profiling in various sheep tissues.

Bakhtiarizade M, Heidari M, Ghanatghestani A Sci Rep. 2024; 14(1):26238.

PMID: 39482374 PMC: 11527890. DOI: 10.1038/s41598-024-76940-7.


Automated scoring of glomerular injury in TNS2-deficient nephropathy.

Shimada S, Tanimoto K, Sasaki H, Taga T, Sasaki T, Imagawa T Exp Anim. 2024; 73(4):370-375.

PMID: 38644233 PMC: 11534489. DOI: 10.1538/expanim.24-0001.


Role of biophysics and mechanobiology in podocyte physiology.

Haydak J, Azeloglu E Nat Rev Nephrol. 2024; 20(6):371-385.

PMID: 38443711 DOI: 10.1038/s41581-024-00815-3.


References
1.
Forbes A, Wadehra M, Mareninov S, Morales S, Shimazaki K, Gordon L . The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem. 2007; 282(36):26542-51. DOI: 10.1074/jbc.M702117200. View

2.
Gee H, Saisawat P, Ashraf S, Hurd T, Vega-Warner V, Fang H . ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest. 2013; 123(8):3243-53. PMC: 3726174. DOI: 10.1172/JCI69134. View

3.
Kruglyak L, Daly M, Lander E . Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996; 58(6):1347-63. PMC: 1915045. View

4.
Tripathi B, Qian X, Mertins P, Wang D, Papageorge A, Carr S . CDK5 is a major regulator of the tumor suppressor DLC1. J Cell Biol. 2014; 207(5):627-42. PMC: 4259810. DOI: 10.1083/jcb.201405105. View

5.
Du X, Qian X, Papageorge A, Schetter A, Vass W, Liu X . Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells. Cancer Res. 2012; 72(17):4405-16. PMC: 6264793. DOI: 10.1158/0008-5472.CAN-12-0777. View